<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28620314</article-id>
<article-id pub-id-type="pmc">5450021</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2017.00357</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Orexin System: The Key for a Healthy Life</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chieffi</surname>
<given-names>Sergio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carotenuto</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Monda</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/181233/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valenzano</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Villano</surname>
<given-names>Ines</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/395663/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Precenzano</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tafuri</surname>
<given-names>Domenico</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salerno</surname>
<given-names>Monica</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Filippi</surname>
<given-names>Nicola</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/434453/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nuccio</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruberto</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Luca</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/181318/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cipolloni</surname>
<given-names>Luigi</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/423043/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cibelli</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mollica</surname>
<given-names>Maria P.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iacono</surname>
<given-names>Diego</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/434292/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nigro</surname>
<given-names>Ersilia</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/434425/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Monda</surname>
<given-names>Marcellino</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Messina</surname>
<given-names>Giovanni</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/168807/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Messina</surname>
<given-names>Antonietta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/181098/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Experimental Medicine, Section of Human Physiology and Unit of Dietetic and Sport Medicine, Università degli Studi della Campania “Luigi Vanvitelli”</institution>
<country>Naples, Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Mental Health, Physical and Preventive Medicine, Clinic of Child and Adolescent Neuropsychiatry, Università degli Studi della Campania “Luigi Vanvitelli”</institution>
<country>Naples, Italy</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Clinical and Experimental Medicine, University of Foggia</institution>
<country>Foggia, Italy</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Motor Sciences and Wellness, University of Naples “Parthenope”</institution>
<country>Naples, Italy</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Medical-Surgical and Dental Specialties, Università degli Studi della Campania “Luigi Vanvitelli”</institution>
<country>Naples, Italy</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Psychiatry, University of Toronto</institution>
<country>Toronto, ON, Canada</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Università degli Studi di Roma La Sapienza</institution>
<country>Rome, Italy</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Department of Biology Università degli Studi di Napoli Federico II</institution>
<country>Naples, Italy</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Neurodevelopmental Research Lab, Biomedical Research Institute of New Jersey</institution>
<country>Morristown, NJ, United States</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>Neuroscience Research, MidAtlantic Neonatology Associates, Atlantic Health System</institution>
<country>Morristown, NJ, United States</country>
</aff>
<aff id="aff11">
<sup>11</sup>
<institution>Neuropathology Research, MANA/Biomedical Research Institute of New Jersey</institution>
<country>Morristown, NJ, United States</country>
</aff>
<aff id="aff12">
<sup>12</sup>
<institution>CEINGE-Biotecnologie Avanzate Scarl</institution>
<country>Naples, Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Giovanni Li Volti, University of Catania, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ivana Sirangelo, Università degli Studi della Campania “Luigi Vanvitelli” Caserta, Italy; Mauro Pessia, University of Perugia, Italy</p>
</fn>
<corresp id="fn001">*Correspondence: Vincenzo Monda <email xlink:type="simple">mondavincenzo@gmail.com</email></corresp>
<corresp id="fn002">Giovanni Messina <email xlink:type="simple">giovanni.messina@unifg.it</email></corresp>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
<fn fn-type="other" id="fn004">
<p>†These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>357</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Chieffi, Carotenuto, Monda, Valenzano, Villano, Precenzano, Tafuri, Salerno, Filippi, Nuccio, Ruberto, De Luca, Cipolloni, Cibelli, Mollica, Iacono, Nigro, Monda, Messina and Messina.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Chieffi, Carotenuto, Monda, Valenzano, Villano, Precenzano, Tafuri, Salerno, Filippi, Nuccio, Ruberto, De Luca, Cipolloni, Cibelli, Mollica, Iacono, Nigro, Monda, Messina and Messina</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The orexin-A/hypocretin-1 and orexin-B/hypocretin-2 are neuropeptides synthesized by a cluster of neurons in the lateral hypothalamus and perifornical area. Orexin neurons receive a variety of signals related to environmental, physiological and emotional stimuli, and project broadly to the entire CNS. Orexin neurons are “multi-tasking” neurons regulating a set of vital body functions, including sleep/wake states, feeding behavior, energy homeostasis, reward systems, cognition and mood. Furthermore, a dysfunction of orexinergic system may underlie different pathological conditions. A selective loss orexin neurons was found in narcolepsia, supporting the crucial role of orexins in maintaining wakefulness. In animal models, orexin deficiency lead to obesity even if the consume of calories is lower than wildtype counterpart. Reduced physical activity appears the main cause of weight gain in these models resulting in energy imbalance. Orexin signaling promotes obesity resistance via enhanced spontaneous physical activity and energy expenditure regulation and the deficiency/dysfunction in orexins system lead to obesity in animal models despite of lower calories intake than wildtype associated with reduced physical activity. Interestingly, orexinergic neurons show connections to regions involved in cognition and mood regulation, including hippocampus. Orexins enhance hippocampal neurogenesis and improve spatial learning and memory abilities, and mood. Conversely, orexin deficiency results in learning and memory deficits, and depression.</p>
</abstract>
<kwd-group>
<kwd>orexin</kwd>
<kwd>obesity</kwd>
<kwd>emotional stress</kwd>
<kwd>narcolepsy</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="86"></ref-count>
<page-count count="9"></page-count>
<word-count count="6464"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Orexin A and B are excitatory hypothalamic neuropeptides playing a relevant role in different physiologic functions such as sleep/wake rhythms and thermoregulation, control of energy metabolism, cardiovascular responses, feeding behavior, and spontaneous physical activity (SPA).</p>
<p>At the end of the last century, Sakurai et al. (<xref ref-type="bibr" rid="B62">1998</xref>) firstly described Hypocretins 1 and 2 as regulators of feeding and appetite behavior, produced in a specific hypothalamic region (Edwards et al., <xref ref-type="bibr" rid="B20">1999</xref>; Haynes et al., <xref ref-type="bibr" rid="B32">2000</xref>, <xref ref-type="bibr" rid="B31">2002</xref>).</p>
<p>More recent studies focused the attention on the role of the orexins in mood and emotional regulation, energetic homeostasis, reward mechanisms, drug addiction, arousal system, and sleep and wakefulness (Peyron et al., <xref ref-type="bibr" rid="B58">2000</xref>; Thannickal et al., <xref ref-type="bibr" rid="B65">2000</xref>; Hara et al., <xref ref-type="bibr" rid="B28">2001</xref>; Yamanaka et al., <xref ref-type="bibr" rid="B80">2003a</xref>; Harris et al., <xref ref-type="bibr" rid="B30">2005</xref>; Narita et al., <xref ref-type="bibr" rid="B56">2006</xref>). However, the function of orexins in metabolism pathways are far to be completely understood.</p>
</sec>
<sec id="s2">
<title>The orexin/hypocretin system</title>
<p>In Mammals, orexin A and orexin B are synthesized in the lateral hypothalamic and perifornical areas (Peyron et al., <xref ref-type="bibr" rid="B59">1998</xref>; Nambu et al., <xref ref-type="bibr" rid="B55">1999</xref>), starting from a common polypeptide precursor (prepro-orexin) through proteolytic processing (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic representation of orexin system. Orexin A and orexin B are derived from a common precursor peptide, prepro-orexin. The actions of orexins are mediated via two G protein-coupled receptors named orexin-1 (OX<sub>1</sub>R) and orexin-2 (OX<sub>2</sub>R) receptors. OX<sub>1</sub>R is selective for orexin A, whereas OX<sub>2</sub>R is a non-selective receptor for both orexin A and orexin B. OX<sub>1</sub>R is coupled exclusively to the Gqsubclass of heterotrimeric G proteins, whereas OX<sub>2</sub>R couples to Gi/oand/or Gq.</p>
</caption>
<graphic xlink:href="fphys-08-00357-g0001"></graphic>
</fig>
<p>Orexin A is a neuropeptide composed of 33 amino acids with an amino(N)-terminal pyroglutamyl residue, two intra-chain disulphide bonds and carboxy (C)-terminal amidation, while Orexin B is a linear neuropeptide sized 28 amino acids, C-terminally amidated. The N-terminal portion presents more variability, whilst the C-terminal portion is similar between the two subtypes. The orexins activity is modulated by their specific receptors (OX<sub>1</sub>R, OX<sub>2</sub>R). OX<sub>1</sub>R presents higher affinity for orexin A than B and transmits signals throughout the G-protein class activating a cascade that leads to an increase in intracellular calcium concentration. By contrast, OX<sub>2</sub>R binds the two subtypes of orexin with similar affinities, probably associated to a G inhibitory protein class (Xu et al., <xref ref-type="bibr" rid="B79">2013</xref>). These differences seem to suggest different physiological roles for OX<sub>1</sub>R and OX<sub>2</sub>R (Trivedi et al., <xref ref-type="bibr" rid="B66">1998</xref>). Different physiological roles of OX1R and OX2R seem to be supported by the observation that mRNAs receptors show complementary distribution patterns (Figure <xref ref-type="fig" rid="F2">2</xref>):</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Schematic drawing showing main projections of orexin neurons. This figure summarizes predicted orexinergic projections in the human brain. Please note that distributions of orexin fibers and receptors (OX<sub>1</sub>R, OX<sub>2</sub>R) are predicted from the results of studies on rodent brains since most histological studies on the orexin system have been carried out in mice and rats. Circles show regions with strong receptor expression and dense orexinergic projections. Orexin neurons originating in the lateral hypothalamic area (LHA) and posterior hypothalamus (PH) regulate sleep and wakefulness and the maintenance of arousal by sending excitatory projections to the entire CNS, excluding the cerebellum, with particularly dense projections to monoaminergic, and cholinergic nuclei in the brain stem and hypothalamic regions including the locus coeruleus (LC, containing noradrenaline), tuberomammillary nucleus (TMN, containing histamine), raphe nuclei (Raphe, containing serotonin), and laterodorsal/pedunclopontine tegmental nuclei (LDT/PPT), containing acetylcholine). Orexin neurons also have links with the reward system through the ventral tegmental area (VTA, containing dopamine) and with the hypothalamic nuclei that stimulate feeding behavior.</p>
</caption>
<graphic xlink:href="fphys-08-00357-g0002"></graphic>
</fig>
<p>- OX<sub>1</sub>R is distributed in prefrontal and infralimbic cortex (IL), hippocampus (CA2), amygdala, stria terminalis bed nucleus (BST), PVT, anterior hypothalamus, dorsal raphe (DR), ventral tegmental area (VTA), locus coeruleus (LC), and laterodorsal tegmental nucleus (LDT)/pedunculopontine nucleus (PPT) (Trivedi et al., <xref ref-type="bibr" rid="B66">1998</xref>; Lu et al., <xref ref-type="bibr" rid="B41">2000</xref>);</p>
<p>- OX<sub>2</sub>R is distributed in amygdala, TMN, Arc, dorsomedial hypothalamic nucleus (DMH), paraventricular nucleus (PVN), LHA, BST, PVT, DR, VTA, LDT/PPT, CA3 in the hippocampus, and medial septal nucleus (Lu et al., <xref ref-type="bibr" rid="B41">2000</xref>).</p>
</sec>
<sec id="s3">
<title>Modulation of orexin neurons</title>
<p>Electrophysiological studies on transgenic mice have identified several neurotransmitters and neuromodulators influencing the activation or inhibition in orexin neurons activity. Specifically, GABA (Xie et al., <xref ref-type="bibr" rid="B78">2006</xref>), noradrenaline and serotonin seem to inhibit the activity of orexin neurons (Yamanaka et al., <xref ref-type="bibr" rid="B82">2003b</xref>), as dopamine acts through activation of α2-adrenoceptors (Yamanaka et al., <xref ref-type="bibr" rid="B81">2006</xref>). Moreover, agonists of ionotropic glutamate receptors tend to excite orexin neurons, while glutamate antagonists inhibit their activity (Li et al., <xref ref-type="bibr" rid="B38">2002</xref>) indicating that glutamatergic neurons can tonically activate orexin neurons. Cholecystokinin, neurotensin, oxytocin, and vasopressin enhance orexin neurons activity (Tsujino et al., <xref ref-type="bibr" rid="B67">2005</xref>; Tsunematsu et al., <xref ref-type="bibr" rid="B68">2008</xref>) by modulation of adenosine and CO<sub>2</sub> concentrations (Liu and Gao, <xref ref-type="bibr" rid="B40">2007</xref>; Williams et al., <xref ref-type="bibr" rid="B77">2007</xref>).</p>
</sec>
<sec id="s4">
<title>Sleep/wake regulation</title>
<p>Interestingly, orexin system seems to be crucial for maintenance of wakefulness state, as demonstrated by narcolepsy caused by orexin deficiency in Human and Animals (Chemelli et al., <xref ref-type="bibr" rid="B8">1999</xref>; Lin et al., <xref ref-type="bibr" rid="B39">1999</xref>). Narcolepsy is a neurological disease affecting ~1 in 2,000 individuals in the United States (Mignot, <xref ref-type="bibr" rid="B51">1998</xref>), characterized by chronic daytime sleepiness, sleep attacks, and possibility of cataplexy, hypnagogic hallucinations and sleep paralysis. These symptoms are not necessary to be present all together and narcolepsy may be identified and diagnosed by standard polysomnography (PSG) at all ages, including childhood. Narcolepsy is the results of orexin-containing neurons loss, which tend to increase their activity during wakefulness activating aminergic nuclei such as locus coeruleus, raphe nuclei, and tuberomamillary nucleus with maintaining wake state and preventing of inappropriate transitions into sleep, particularly REM sleep phases (Saper et al., <xref ref-type="bibr" rid="B63">2001</xref>; España and Scammell, <xref ref-type="bibr" rid="B21">2011</xref>). Narcolepsy is usually classified into two subtypes: (a) Narcolepsy with cataplexy (type 1); and (b) Narcolepsy without cataplexy (type 2). On the other hand, the orexin in sleep/wake regulation and pathophysiology of narcolepsy may be not limited to the activation/deactivation of cataplexic phenomena and/or sleep attacks. In fact, affected children and adolescents present specific cognitive impairments (Posar et al., <xref ref-type="bibr" rid="B60">2014</xref>), which pinpoint the close relationship between sleep and cognition (Esposito and Carotenuto, <xref ref-type="bibr" rid="B22">2014</xref>). Moreover, probably due to the same role in sleep modulation, orexin seems to be also involved in the pathogenesis of migraine (Rainero et al., <xref ref-type="bibr" rid="B61">2008</xref>) as suggested by the link between NREM sleep instability and risk of cognitive impairments and behavioral problems (McCoy and Strecker, <xref ref-type="bibr" rid="B44">2011</xref>; Bruni et al., <xref ref-type="bibr" rid="B4">2012</xref>; Colonna et al., <xref ref-type="bibr" rid="B16">2015</xref>; Carotenuto et al., <xref ref-type="bibr" rid="B5">2016</xref>, Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Loss of orexin signaling could cause cataplexy by reducing activity in motor excitatory systems of brainstem or by providing less suppression of the motor inhibitory systems. Loss of orexin could cause sleepiness by reducing activity in the cholinergic and monoaminergic arousal systems or by reducing inhibition of sleep-promoting neurons in the rostral hypothalamus (preoptic area).</p>
</caption>
<graphic xlink:href="fphys-08-00357-g0003"></graphic>
</fig>
</sec>
<sec id="s5">
<title>Feeding behaviors and energy homeostasis</title>
<p>Orexin A seems to regulate feeding behaviors and energy expenditure as evidenced by the intracerebroventricular (icv) injection of orexins effects during the light period, which induces feeding behavior in rodents and zebrafishes, probably for a direct action on lateral hypothalamic area containing neurons modulated by glucose concentration. In fact, the high concentrations of glucose and leptin tend to hyperpolarize orexinergic neurons, while low concentrations of glucose and ghrelin depolarize them. Therefore, the orexinergic system discriminate physiological variation in glucose levels due to meals modulating in this way energy balance according to food intake (Monda et al., <xref ref-type="bibr" rid="B53">2008</xref>; Messina et al., <xref ref-type="bibr" rid="B47">2014</xref>). Moreover, transgenic mice with gradual and then loss of hypothalamic orexin-containing neurons show feeding abnormalities and dysregulation in energy homeostasis determining obesity despite the reduction of food intake/calories. Interestingly, it has been reported an increased prevalence of obesity in narcoleptic subjects in all ages (Yokobori et al., <xref ref-type="bibr" rid="B84">2011</xref>).</p>
<p>Shiuchi et al. (<xref ref-type="bibr" rid="B64">2009</xref>) observed that the regulation mediated by orexinergic system on muscle glucose metabolism is due to activation of β<sub>2</sub>-adrenergic signaling and consequently peripheral energy expenditure. A persistent wake-state mediated by orexins could also be important for food intake motivation. When facing reduced food availability, animals adapt with a longer awake period, revolutionizing their normal pattern of activity (Viggiano et al., <xref ref-type="bibr" rid="B73">2009</xref>). During starvation the activation of orexin neurons mediated by low leptin and glucose levels, might modulate their activity according to energy expenditure and stores to maintain wakefulness, whilst orexin neuron-ablated mice fail to respond to fasting with increased wakefulness and activity (Viggiano et al., <xref ref-type="bibr" rid="B72">2010</xref>; Messina et al., <xref ref-type="bibr" rid="B48">2013</xref>; Chieffi et al., <xref ref-type="bibr" rid="B14">2017</xref>; Villano et al., <xref ref-type="bibr" rid="B74">2017</xref>). These data confirm that orexin neurons mediate energy balance and arousal, maintaining a consolidated state of wakefulness in hungry animals in order to promote alertness.</p>
</sec>
<sec id="s6">
<title>The role of orexin system in obesity</title>
<p>Obesity is a complex multifactorial condition lowering health quality and many effects such as metabolic syndrome, type 2 diabetes mellitus, coronary heart disease, sleep apnea syndrome, and reduced in life expectancy (Must et al., <xref ref-type="bibr" rid="B54">1999</xref>). In the last decades, the incidence of obesity has increased both in children and adults worldwide (Flegal et al., <xref ref-type="bibr" rid="B26">2010</xref>). Environmental and genetic factors cause large variations among human susceptibility to obesity. Physical activity and the so called “non-exercise induced thermogenesis” (NEAT) are factors determining this variability and susceptibility. The term NEAT includes all types of energy expenditure not associated with formal exercise, such as standing and fidgeting (Levine, <xref ref-type="bibr" rid="B36">2002</xref>). A complementary concept to that of NEAT is the spontaneous physical activity (SPA) describing any type of physical activity not qualified as voluntary exercise. Together NEAT and SPA are hereditable but not interchangeable, because NEAT refers to energy expenditure while SPA describes the types of physical activity resulting in NEAT. Therefore, SPA induces an important variability in sensitivity to obese subject that spend less time standing than leans (Levine et al., <xref ref-type="bibr" rid="B37">2005</xref>). Orexin signaling would promote obesity resistance via enhanced SPA and energy expenditure regulation and the deficiency/dysfunction in orexins system lead to obesity in animal models despite of lower calories intake than wildtype associated with reduced physical activity. On the other hand, the body weight regulation seems to be complex according to the lack of orexin neurons. In 2012, Perez-Leighton et al. (<xref ref-type="bibr" rid="B57">2012</xref>) highlighted the protective role of intratecal administration orexin A against obesity in mice models.</p>
<p>Orexin A has also been discovered to promote SPA and NEAT as effect of administration into specific cerebral areas (i.e., rostral LH, hypothalamic paraventricular nucleus, nucleus accumbens, locus coeruleus, dorsal raphe nucleus, tuberomamillary nucleus, substantia nigra, Hara et al., <xref ref-type="bibr" rid="B29">2005</xref>). In this light, orexinergic neurotransmission may be an interesting and new pharmacologic target for obesity therapy (Zink et al., <xref ref-type="bibr" rid="B86">2014</xref>). Low levels of orexin in CNS and peripheral tissues were found in animal models of obesity diet-induced (Hara et al., <xref ref-type="bibr" rid="B29">2005</xref>), and adipose tissue in obese humans subjects showed lower concentrations of orexin and reduced in its receptors activity (Hara et al., <xref ref-type="bibr" rid="B29">2005</xref>). A study conducted by Levin et al. (<xref ref-type="bibr" rid="B35">1997</xref>) on Sprague Dawley rats showed that models fed with a high-fat diet gained no more weight than chow-fed controls. Obesity prone (OP) and obesity resistant (OR) models present different profiles in weight gaining despite of no differences in energy intake (Levin et al., <xref ref-type="bibr" rid="B35">1997</xref>; Messina et al., <xref ref-type="bibr" rid="B50">2015</xref>; Messina A. et al., <xref ref-type="bibr" rid="B46">2016</xref>). The OR group showed lower body weight and fat mass on a low-fat diet and gain less weight when fed with high-fat diet than OP group. Furthermore, OR rats lean group suggest that the negative caloric benefit of OXA-induced SPA appears to outweigh the positive calories due to OXA-induced hyperphagia (Levin et al., <xref ref-type="bibr" rid="B35">1997</xref>; Carotenuto et al., <xref ref-type="bibr" rid="B6">2010</xref>; Esposito et al., <xref ref-type="bibr" rid="B24">2013</xref>). OXA action on SPA had a longer duration when compared with that above food intake (Carotenuto et al., <xref ref-type="bibr" rid="B7">2011</xref>; Bellini et al., <xref ref-type="bibr" rid="B2">2013</xref>); OR rats have higher endogenous SPA thus reflecting their higher sensitivity to SPA- promoting stimuli such as lower caloric intake. By contrast OP rats displayed lower SPA endogenous levels after a high-fat diet administration if compared to their OR group counterpart (Levin et al., <xref ref-type="bibr" rid="B35">1997</xref>; Esposito et al., <xref ref-type="bibr" rid="B23">2012a</xref>). Conversely, obesity tends to increase also the prevalence of migraine in all ages of life (Esposito et al., <xref ref-type="bibr" rid="B25">2012b</xref>; Verrotti et al., <xref ref-type="bibr" rid="B70">2012</xref>, <xref ref-type="bibr" rid="B69">2015</xref>).</p>
</sec>
<sec id="s7">
<title>Reward system</title>
<p>Orexin system seems to play a unified role in coordinating motivational activation under numerous behavioral conditions (James et al., <xref ref-type="bibr" rid="B34">2016</xref>) as showed, for example, by its involving in alcohol use and drug-addiction (Martin-Fardon et al., <xref ref-type="bibr" rid="B43">2016</xref>; Walker and Lawrence, <xref ref-type="bibr" rid="B75">2016</xref>). Recent studies focused their attention on reward system modulation by orexin system. Treating narcoleptic patients with amphetamine-like drugs (Di Bernardo et al., <xref ref-type="bibr" rid="B19">2014</xref>) did not lead to addiction to these drugs (Monda et al., <xref ref-type="bibr" rid="B52">2014</xref>). Wild-type mice are more susceptible to developing morphine dependence in comparison with orexin knockout mice (Chieffi et al., <xref ref-type="bibr" rid="B11">2014b</xref>). Furthermore, reward brain circuits in humans affected by narcolepsy were identified as abnormal (Viggiano et al., <xref ref-type="bibr" rid="B71">2014</xref>) However, the mismatch between predicted reward and reward subsequently received was significantly higher in Parkinson's disease (PD) compared to narcoleptic, independent of reward magnitude and valence as showed by cataplexy that may be triggered by both positive and negative emotions (Mensen et al., <xref ref-type="bibr" rid="B45">2015</xref>).</p>
<p>Regulatory mechanisms at the base of reward system are shown in Figure <xref ref-type="fig" rid="F4">4</xref>. It seems to be clear that orexin neurons modulate reward system and play a predominant role in mechanisms of drug addiction. Many reports suggest a critical role of orexin signaling in neural plastic effects at glutamatergic synapses in the ventral tegmental area (VTA) (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Input and output of orexin neurons at interface of sleep, stress, reward, and energy homeostasis. Orexin neurons in the lateral hypothalamic area (LHA) and posterior hypothalamus (PH) are placed to provide a link among limbic system, energy homeostasis, brainstem and other systems. Arrows show excitatory projections and broken arrows inhibitory projections. Gray semicircles indicate OX1R and black semicircles indicate OX2R. Neurotransmitters/modulators are underlined. LC, DR, and TMN are wake-active regions, VLPO is sleep-active region, and LDT/PPT is REM-active region. Orexin neurons promote wakefulness through monoaminergic nuclei that are wake-active. Stimulation of dopaminergic centers by orexins modulates reward systems (VTA). Peripheral metabolic signals influence orexin neuronal activity to coordinate arousal and energy homeostasis. Stimulation of neuropeptide Y neurons by orexin increases food intake. The SCN, the central body clock, sends input to orexin neurons via the DMH. Input from the limbic system (amygdala and BST) might be important to regulate the activity of orexin neurons upon emotional stimuli to evoke emotional arousal or fear-related responses. Abbreviations: BST, bed nucleus of the stria terminalis; VLPO, ventrolateral preoptic area; LC, locus ceruleus; DR, dorsal raphe; TMN, tuberomammillary nucleus; LDT, laterodorsal tegmental nucleus; PPT, pedunculopontine tegmental nucleus; VTA, ventral tegmental area; SCN, suprachiasmatic nucleus; DMH, dorsomedial hypothalamus; Arc, arcuate nucleus.</p>
</caption>
<graphic xlink:href="fphys-08-00357-g0004"></graphic>
</fig>
</sec>
<sec id="s8">
<title>Links with brain</title>
<p>Animal studies suggest that orexinergic system may enhance hippocampal neurogenesis influencing learning and memory processes. In 2004, Wayner et al. (<xref ref-type="bibr" rid="B76">2004</xref>) reported that local dentate gyrus perfusion with orexin-A in anesthetized rats enhanced long-term potentiation (LTP) strengthen the link between structural and functional hippocampal plasticity. Moreover, Wayner et al. (<xref ref-type="bibr" rid="B76">2004</xref>) showed that LTP enhancement may be blocked in SB-334867 pre-treated rats SB-334867, a specific Ox1R antagonist (Wayner et al., <xref ref-type="bibr" rid="B76">2004</xref>). The effects of dentate gyrus-OX1Rs antagonization on LTP occurred also in freely moving rats impairing spatial memory in Morris water maze (Wayner et al., <xref ref-type="bibr" rid="B76">2004</xref>). Some studies examined the effects of the administration of orexin-A in rats treated with Pentylenetetrazol (PTZ) (Zhao et al., <xref ref-type="bibr" rid="B85">2014</xref>). PTZ induces seizures resulting in the hippocampal atrophy, learning and memory deficits and decrease of cerebrospinal fluid-level of orexin-A (Coppola et al., <xref ref-type="bibr" rid="B17">2010</xref>), while the intracerebroventricular injection of orexin-A in PTZ-kindled rats tend to attenuate these impairments, enhancing neurogenesis in the dentate gyrus (Zhao et al., <xref ref-type="bibr" rid="B85">2014</xref>). Interestingly, in rats treated with orexin-A more than 50% of newborn cells differentiated into neurons, whereas only approximately 30% of the newborn cells differentiated into neurons in the control group (Zhao et al., <xref ref-type="bibr" rid="B85">2014</xref>).</p>
<p>Moreover, Orexin-A seems to be implicated in social memory, the ability to distinguish and remember familiar from novel conspecifics (Yang et al., <xref ref-type="bibr" rid="B83">2013</xref>). Yang et al. (<xref ref-type="bibr" rid="B83">2013</xref>) reported that orexin/ataxin-3-transgenic (AT) mice, in which orexin neurons degenerate by 3 months of age, displayed deficits in long-term social memory. Nasal administration of exogenous orexin-A restored social memory and enhanced synaptic plasticity in the hippocampus (Yang et al., <xref ref-type="bibr" rid="B83">2013</xref>). A decrease of Orexin-A was found in animal models of depression and its intracerebroventricular administration reduced depression symptoms and increases the number of cells in the dentate gyrus (Arendt et al., <xref ref-type="bibr" rid="B1">2013</xref>). Then, it is possible that the enhancement of cell proliferation in the dentate gyrus by orexin-A might have an antidepressive-like effect.</p>
<p>Interestingly, physical exercise produces an increase of orexin-A level in cerebrospinal fluid of rats, dogs and cats, and in plasma of humans (Messina G. et al., <xref ref-type="bibr" rid="B49">2016</xref>). Note that the orexin-A rapidly cross the blood-brain barrier, probably by simple diffusion, having a high degree of lipophilicity. Furthermore, physical exercise is (a) an effective tool for enhancing cognitive performance and regulating mood and (b) produced morphological and functional changes of brain regions that play central roles in successful everyday functioning, such as frontal and temporal cortices, and the hippocampus located in the inner (medial) region of the temporal lobe. The frontal lobe is important for cognitive function (Iavarone et al., <xref ref-type="bibr" rid="B33">2007</xref>; Chieffi et al., <xref ref-type="bibr" rid="B15">2009</xref>, <xref ref-type="bibr" rid="B13">2012</xref>; Boscia et al., <xref ref-type="bibr" rid="B3">2015</xref>), the temporal lobe for memory function (Chieffi et al., <xref ref-type="bibr" rid="B9">2004</xref>, <xref ref-type="bibr" rid="B10">2014a</xref>, <xref ref-type="bibr" rid="B12">2015</xref>; Marra et al., <xref ref-type="bibr" rid="B42">2013</xref>; Franco et al., <xref ref-type="bibr" rid="B27">2014</xref>). The factors most likely involved in exercise-induced hippocampal neurogenesis are the microcirculation and the production of neurotrophic factors such as the BDNF, VEGF, and IGF-1 (Cotman et al., <xref ref-type="bibr" rid="B18">2007</xref>). Another putative factor that might contribute to the beneficial effects of exercise is the orexin-A.</p>
</sec>
<sec id="s9">
<title>Concluding remarks</title>
<p>Orexin is necessary for healthy life because of the important and relevant homeostatic functions controlled and organized directly or not. Orexin role is not only limited to the brain areas, because it involved also in metabolic regulation.</p>
</sec>
<sec id="s10">
<title>Author contributions</title>
<p>AM, VM, AV, IV, MR: conceived the study, participated in its design, and wrote the manuscript. FP, DT, MS, NF, FN, LC, EN: contributed to the conception and design. SC, MC, VD, GC, MPM, DI, MM, GM: drafted the article and revised it critically for important intellectual content. DI revised grammar and English form; GM: final approval of the version to be published. All authors read and approved the final manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer IS declared a shared affiliation, though no other collaboration, with several of the authors MC, FP, MR to the handling Editor, who ensured that the process nevertheless met the standards of a fair and objective review.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was supported by grants of “Section of Human Physiology and Unit of Dietetic and Sport Medicine and Department of Experimental Medicine,” Università degli Studi della Campania “L. Vanvitelli”.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendt</surname><given-names>D. H.</given-names></name><name><surname>Ronan</surname><given-names>P. J.</given-names></name><name><surname>Oliver</surname><given-names>K. D.</given-names></name><name><surname>Callahan</surname><given-names>L. B.</given-names></name><name><surname>Summers</surname><given-names>T. R.</given-names></name><name><surname>Summers</surname><given-names>C. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Depressive behavior and activation of the orexin/hypocretin system</article-title>. <source/>Behav. Neurosci.
<volume>127</volume>, <fpage>86</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1037/a0031442</pub-id><pub-id pub-id-type="pmid">23398442</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellini</surname><given-names>B.</given-names></name><name><surname>Arruda</surname><given-names>M.</given-names></name><name><surname>Cescut</surname><given-names>A.</given-names></name><name><surname>Saulle</surname><given-names>C.</given-names></name><name><surname>Persico</surname><given-names>A.</given-names></name><name><surname>Carotenuto</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Headache and comorbidity in children and adolescents</article-title>. <source/>J. Headache Pain.
<volume>14</volume>:<fpage>79</fpage>. <pub-id pub-id-type="doi">10.1186/1129-2377-14-79</pub-id><pub-id pub-id-type="pmid">24063537</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boscia</surname><given-names>F.</given-names></name><name><surname>Passaro</surname><given-names>C.</given-names></name><name><surname>Gigantino</surname><given-names>V.</given-names></name><name><surname>Perdonà</surname><given-names>S.</given-names></name><name><surname>Franco</surname><given-names>R.</given-names></name><name><surname>Portella</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>High levels of GPR30 protein in human testicular carcinoma <italic>in situ</italic> and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness</article-title>. <source/>J. Cell. Physiol.
<volume>230</volume>, <fpage>1290</fpage>–<lpage>1297</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24864</pub-id><pub-id pub-id-type="pmid">25413376</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruni</surname><given-names>O.</given-names></name><name><surname>Kohler</surname><given-names>M.</given-names></name><name><surname>Novelli</surname><given-names>L.</given-names></name><name><surname>Kennedy</surname><given-names>D.</given-names></name><name><surname>Lushington</surname><given-names>K.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The role of NREM sleep instability in child cognitive performance</article-title>. <source/>Sleep
<volume>35</volume>, <fpage>649</fpage>–<lpage>656</lpage>. <pub-id pub-id-type="doi">10.5665/sleep.1824</pub-id><pub-id pub-id-type="pmid">22547891</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carotenuto</surname><given-names>M.</given-names></name><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Cortese</surname><given-names>S.</given-names></name><name><surname>Laino</surname><given-names>D.</given-names></name><name><surname>Verrotti</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Children with developmental dyslexia showed greater sleep disturbances than controls including problems initiating and maintaining sleep</article-title>. <source/>Acta Paediatr.
<volume>105</volume>, <fpage>1079</fpage>–<lpage>1082</lpage>. <pub-id pub-id-type="doi">10.1111/apa.13472</pub-id><pub-id pub-id-type="pmid">27173764</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carotenuto</surname><given-names>M.</given-names></name><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Pascotto</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Migraine and enuresis in children: an unusual correlation?</article-title>
<source/>Med. Hypotheses
<volume>75</volume>, <fpage>120</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2010.02.004</pub-id><pub-id pub-id-type="pmid">20185246</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carotenuto</surname><given-names>M.</given-names></name><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Precenzano</surname><given-names>F.</given-names></name><name><surname>Castaldo</surname><given-names>L.</given-names></name><name><surname>Roccella</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Cosleeping in childhood migraine</article-title>. <source/>Minerva Pediatr.
<volume>63</volume>, <fpage>105</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="pmid">21487373</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chemelli</surname><given-names>R. M.</given-names></name><name><surname>Willie</surname><given-names>J. T.</given-names></name><name><surname>Sinton</surname><given-names>C. M.</given-names></name><name><surname>Elmquist</surname><given-names>J. K.</given-names></name><name><surname>Scammell</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation</article-title>. <source/>Cell
<volume>98</volume>, <fpage>437</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81973-X</pub-id><pub-id pub-id-type="pmid">10481909</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Conson</surname><given-names>M.</given-names></name><name><surname>Carlomagno</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Movement velocity effects on kinaesthetic localization of spatial positions</article-title>. <source/>Exp. Brain Res.
<volume>158</volume>, <fpage>421</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-004-1916-z</pub-id><pub-id pub-id-type="pmid">15127172</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Iachini</surname><given-names>T.</given-names></name><name><surname>Iavarone</surname><given-names>A.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Monda</surname><given-names>M.</given-names></name></person-group> (<year>2014a</year>). <article-title>Flanker interference effects in a line bisection task</article-title>. <source/>Exp. Brain Res.
<volume>232</volume>, <fpage>1327</fpage>–<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-014-3851-y</pub-id><pub-id pub-id-type="pmid">24496492</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Iavarone</surname><given-names>A.</given-names></name><name><surname>Iaccarino</surname><given-names>L.</given-names></name><name><surname>La Marra</surname><given-names>M.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>De Luca</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2014b</year>). <article-title>Age-related differences in distractor interference on line bisection</article-title>. <source/>Exp. Brain Res.
<volume>232</volume>, <fpage>3659</fpage>–<lpage>3664</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-014-4056-0</pub-id><pub-id pub-id-type="pmid">25092273</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Iavarone</surname><given-names>A.</given-names></name><name><surname>La Marra</surname><given-names>M.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Dalia</surname><given-names>C.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Vulnerability to distraction in schizophrenia</article-title>. <source/>J Psychiatry
<volume>18</volume>, <fpage>228</fpage>
<pub-id pub-id-type="doi">10.4172/Psychiatry.1000228</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Iavarone</surname><given-names>A.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Monda</surname><given-names>M.</given-names></name><name><surname>Carlomagno</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Effect of a visual distractor on line bisection</article-title>. <source/>Exp. Brain Res.
<volume>219</volume>, <fpage>489</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-012-3106-8</pub-id><pub-id pub-id-type="pmid">22576681</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Villano</surname><given-names>I.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Exercise influence on hippocampal function: possible involvement of orexin-A</article-title>. <source/>Front. Physiol.
<volume>8</volume>:<fpage>85</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00085</pub-id><pub-id pub-id-type="pmid">28261108</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Secchi</surname><given-names>C.</given-names></name><name><surname>Gentilucci</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Deictic word and gesture production: their interaction</article-title>. <source/>Behav. Brain Res.
<volume>203</volume>, <fpage>200</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2009.05.003</pub-id><pub-id pub-id-type="pmid">19433113</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colonna</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>A. B.</given-names></name><name><surname>Pal</surname><given-names>D. K.</given-names></name><name><surname>Gringras</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Novel mechanisms, treatments, and outcome measures in childhood sleep</article-title>. <source/>Front. Psychol.
<volume>6</volume>:<fpage>602</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2015.00602</pub-id><pub-id pub-id-type="pmid">26029140</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>G.</given-names></name><name><surname>Arcieri</surname><given-names>S.</given-names></name><name><surname>D'Aniello</surname><given-names>A.</given-names></name><name><surname>Messana</surname><given-names>T.</given-names></name><name><surname>Verrotti</surname><given-names>A.</given-names></name><name><surname>Signoriello</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats</article-title>. <source/>Seizure
<volume>19</volume>, <fpage>296</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.seizure.2010.03.004</pub-id><pub-id pub-id-type="pmid">20399683</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotman</surname><given-names>C. W.</given-names></name><name><surname>Berchtold</surname><given-names>N. C.</given-names></name><name><surname>Christie</surname><given-names>L. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Exercise builds brain health: key roles of growth factor cascades and inflammation</article-title>. <source/>Trends Neurosci.
<volume>30</volume>, <fpage>464</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2007.06.011</pub-id><pub-id pub-id-type="pmid">17765329</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Bernardo</surname><given-names>G.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Capasso</surname><given-names>S.</given-names></name><name><surname>Del Gaudio</surname><given-names>S.</given-names></name><name><surname>Cipollaro</surname><given-names>M.</given-names></name><name><surname>Peluso</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Sera of overweight people promote <italic>in vitro</italic> adipocyte differentiation of bone marrow stromal cells</article-title>. <source/>Stem Cell Res. Ther.
<volume>5</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/scrt393</pub-id><pub-id pub-id-type="pmid">24405848</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>C. M. B.</given-names></name><name><surname>Abusnana</surname><given-names>S.</given-names></name><name><surname>Sunter</surname><given-names>D.</given-names></name><name><surname>Murphy</surname><given-names>K. G.</given-names></name><name><surname>Ghatei</surname><given-names>M. A.</given-names></name><name><surname>Bloom</surname><given-names>S. R.</given-names></name></person-group> (<year>1999</year>). <article-title>The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin</article-title>. <source/>J. Endocrinol.
<volume>160</volume>, <fpage>R7</fpage>–<lpage>R12</lpage>. <pub-id pub-id-type="doi">10.1677/joe.0.160R007</pub-id><pub-id pub-id-type="pmid">10077743</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>España</surname><given-names>R. A.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Sleep neurobiology from a clinical perspective</article-title>. <source/>Sleep
<volume>34</volume>, <fpage>845</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.5665/SLEEP.1112</pub-id><pub-id pub-id-type="pmid">21731134</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Carotenuto</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Intellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioning</article-title>. <source/>J. Intellect. Disabil. Res.
<volume>58</volume>, <fpage>421</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1111/jir.12036</pub-id><pub-id pub-id-type="pmid">23517422</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Pascotto</surname><given-names>A.</given-names></name><name><surname>Gallai</surname><given-names>B.</given-names></name><name><surname>Parisi</surname><given-names>L.</given-names></name><name><surname>Roccella</surname><given-names>M.</given-names></name><name><surname>Marotta</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Can headache impair intellectual abilities in children? an observational study</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>8</volume>, <fpage>509</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S36863</pub-id><pub-id pub-id-type="pmid">23139628</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Roccella</surname><given-names>M.</given-names></name><name><surname>Parisi</surname><given-names>L.</given-names></name><name><surname>Gallai</surname><given-names>B.</given-names></name><name><surname>Carotenuto</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Hypersomnia in children affected by migraine without aura: A questionnaire-based case-control study</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>9</volume>, <fpage>289</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S42182</pub-id><pub-id pub-id-type="pmid">23459616</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Verrotti</surname><given-names>A.</given-names></name><name><surname>Gimigliano</surname><given-names>F.</given-names></name><name><surname>Ruberto</surname><given-names>M.</given-names></name><name><surname>Agostinelli</surname><given-names>S.</given-names></name><name><surname>Scuccimarra</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012b</year>). <article-title>Motor coordination impairment and migraine in children: a new comorbidity?</article-title>
<source/>Eur. J. Pediatr.
<volume>171</volume>, <fpage>1599</fpage>–<lpage>1604</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-012-1759-8</pub-id><pub-id pub-id-type="pmid">22673929</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flegal</surname><given-names>K. M.</given-names></name><name><surname>Carroll</surname><given-names>M. D.</given-names></name><name><surname>Ogden</surname><given-names>C. L.</given-names></name><name><surname>Curtin</surname><given-names>L. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Prevalence and trends in obesity among US adults, 1999-2008</article-title>. <source/>JAMA
<volume>303</volume>, <fpage>235</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2009.2014</pub-id><pub-id pub-id-type="pmid">20071471</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>R.</given-names></name><name><surname>Zappavigna</surname><given-names>S.</given-names></name><name><surname>Gigantino</surname><given-names>V.</given-names></name><name><surname>Luce</surname><given-names>A.</given-names></name><name><surname>Cantile</surname><given-names>M.</given-names></name><name><surname>Cerrone</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion</article-title>. <source/>J. Exp. Clin. Cancer Res.
<volume>33</volume>:<fpage>48</fpage>. <pub-id pub-id-type="doi">10.1186/1756-9966-33-48</pub-id><pub-id pub-id-type="pmid">24893613</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>J.</given-names></name><name><surname>Beuckmann</surname><given-names>C. T.</given-names></name><name><surname>Nambu</surname><given-names>T.</given-names></name><name><surname>Willie</surname><given-names>J. T.</given-names></name><name><surname>Chemelli</surname><given-names>R. M.</given-names></name><name><surname>Sinton</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity</article-title>. <source/>Neuron
<volume>30</volume>, <fpage>345</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00293-8</pub-id><pub-id pub-id-type="pmid">11394998</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>J.</given-names></name><name><surname>Yanagisawa</surname><given-names>M.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions</article-title>. <source/>Neurosci. Lett.
<volume>380</volume>, <fpage>239</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.01.046</pub-id><pub-id pub-id-type="pmid">15862893</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>G. C.</given-names></name><name><surname>Wimmer</surname><given-names>M.</given-names></name><name><surname>Aston-Jones</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>A role for lateral hypothalamic orexin neurons in reward seeking</article-title>. <source/>Nature
<volume>437</volume>, <fpage>556</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1038/nature04071</pub-id><pub-id pub-id-type="pmid">16100511</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>A. C.</given-names></name><name><surname>Chapman</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>C.</given-names></name><name><surname>Moore</surname><given-names>G. B.</given-names></name><name><surname>Cawthorne</surname><given-names>M. A.</given-names></name><name><surname>Tadayyon</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice</article-title>. <source/>Regul. Pept.
<volume>104</volume>, <fpage>153</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-0115(01)00358-5</pub-id><pub-id pub-id-type="pmid">11830290</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>A. C.</given-names></name><name><surname>Jackson</surname><given-names>B.</given-names></name><name><surname>Chapman</surname><given-names>H.</given-names></name><name><surname>Tadayyon</surname><given-names>M.</given-names></name><name><surname>Johns</surname><given-names>A.</given-names></name><name><surname>Porter</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>A selective orexin-1 receptor antagonist reduces food consumption in male and female rats</article-title>. <source/>Regul. Pept.
<volume>96</volume>, <fpage>45</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-0115(00)00199-3</pub-id><pub-id pub-id-type="pmid">11102651</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iavarone</surname><given-names>A.</given-names></name><name><surname>Patruno</surname><given-names>M.</given-names></name><name><surname>Galeone</surname><given-names>F.</given-names></name><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Carlomagno</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Brief report: error pattern in an autistic savant calendar calculator</article-title>. <source/>J. Autism Dev. Disord.
<volume>37</volume>, <fpage>775</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-006-0190-2</pub-id><pub-id pub-id-type="pmid">16900402</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>M. H.</given-names></name><name><surname>Mahler</surname><given-names>S. V.</given-names></name><name><surname>Moorman</surname><given-names>D. E.</given-names></name><name><surname>Aston-Jones</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Decade of orexin/hypocretin and addiction: where are we now?</article-title>
<source/>Curr. Top. Behav. Neurosci. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1007/7854_2016_57</pub-id><pub-id pub-id-type="pmid">28012090</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>B. E.</given-names></name><name><surname>Dunn-Meynell</surname><given-names>A. A.</given-names></name><name><surname>Balkan</surname><given-names>B.</given-names></name><name><surname>Keesey</surname><given-names>R. E.</given-names></name></person-group> (<year>1997</year>). <article-title>Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats</article-title>. <source/>Am. J. Physiol.
<volume>273</volume>, <fpage>R725</fpage>–<lpage>R730</lpage>. <pub-id pub-id-type="pmid">9277561</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>J. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Non-exercise activity thermogenesis (NEAT)</article-title>. <source/>Best Pract. Res. Clin. Endocrinol. Metab.
<volume>16</volume>, <fpage>679</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1053/beem.2002.0227</pub-id><pub-id pub-id-type="pmid">12468415</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>J. A.</given-names></name><name><surname>Lanningham-Foster</surname><given-names>L. M.</given-names></name><name><surname>McCrady</surname><given-names>S. K.</given-names></name><name><surname>Krizan</surname><given-names>A. C.</given-names></name><name><surname>Olson</surname><given-names>L. R.</given-names></name><name><surname>Kane</surname><given-names>P. H.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Interindividual variation in posture allocation: possible role in human obesity</article-title>. <source/>Science
<volume>307</volume>, <fpage>584</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1126/science.1106561</pub-id><pub-id pub-id-type="pmid">15681386</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>X. B.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>van den Pol</surname><given-names>A. N.</given-names></name></person-group> (<year>2002</year>). <article-title>Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system</article-title>. <source/>Neuron
<volume>36</volume>, <fpage>1169</fpage>–<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)01132-7</pub-id><pub-id pub-id-type="pmid">12495630</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Faraco</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Kadotani</surname><given-names>H.</given-names></name><name><surname>Rogers</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene</article-title>. <source/>Cell
<volume>98</volume>, <fpage>365</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81965-0</pub-id><pub-id pub-id-type="pmid">10458611</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z. W.</given-names></name><name><surname>Gao</surname><given-names>X. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect</article-title>. <source/>J. Neurophysiol.
<volume>97</volume>, <fpage>837</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00873.2006</pub-id><pub-id pub-id-type="pmid">17093123</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X. Y.</given-names></name><name><surname>Bagnol</surname><given-names>D.</given-names></name><name><surname>Burke</surname><given-names>S.</given-names></name><name><surname>Akil</surname><given-names>H.</given-names></name><name><surname>Watson</surname><given-names>S. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting</article-title>. <source/>Horm. Behav.
<volume>37</volume>, <fpage>335</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1006/hbeh.2000.1584</pub-id><pub-id pub-id-type="pmid">10860677</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname><given-names>L.</given-names></name><name><surname>Cantile</surname><given-names>M.</given-names></name><name><surname>Scognamiglio</surname><given-names>G.</given-names></name><name><surname>Perdonà</surname><given-names>S.</given-names></name><name><surname>La Mantia</surname><given-names>E.</given-names></name><name><surname>Cerrone</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Deregulation of HOX B13 expression in urinary bladder cancer progression</article-title>. <source/>Curr. Med. Chem.
<volume>20</volume>, <fpage>833</fpage>–<lpage>839</lpage>. <pub-id pub-id-type="doi">10.2174/0929867311320060008</pub-id><pub-id pub-id-type="pmid">23276138</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Fardon</surname><given-names>R.</given-names></name><name><surname>Cauvi</surname><given-names>G.</given-names></name><name><surname>Kerr</surname><given-names>T. M.</given-names></name><name><surname>Weiss</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food</article-title>. <source/>Addict. Biol. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/adb.12441</pub-id><pub-id pub-id-type="pmid">27558790</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>J. G.</given-names></name><name><surname>Strecker</surname><given-names>R. E.</given-names></name></person-group> (<year>2011</year>). <article-title>The cognitive cost of sleep lost</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>96</volume>, <fpage>564</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2011.07.004</pub-id><pub-id pub-id-type="pmid">21875679</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mensen</surname><given-names>A.</given-names></name><name><surname>Poryazova</surname><given-names>R.</given-names></name><name><surname>Huegli</surname><given-names>G.</given-names></name><name><surname>Baumann</surname><given-names>C. R.</given-names></name><name><surname>Schwartz</surname><given-names>S.</given-names></name><name><surname>Khatami</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>The roles of dopamine and hypocretin in reward: a electroencephalographic study</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0142432</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142432</pub-id><pub-id pub-id-type="pmid">26599765</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>De Fusco</surname><given-names>C.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><name><surname>Esposito</surname><given-names>M.</given-names></name><name><surname>Moscatelli</surname><given-names>F.</given-names></name><name><surname>Valenzano</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Role of the orexin system on the hypothalamus-pituitary-thyroid axis</article-title>. <source/>Front. Neural Circuits
<volume>10</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2016.00066</pub-id><pub-id pub-id-type="pmid">27610076</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Dalia</surname><given-names>C.</given-names></name><name><surname>Tafuri</surname><given-names>D.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><name><surname>Palmieri</surname><given-names>F.</given-names></name><name><surname>Dato</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Orexin-A controls sympathetic activity and eating behavior</article-title>. <source/>Front. Psychol.
<volume>5</volume>:<fpage>997</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2014.00997</pub-id><pub-id pub-id-type="pmid">25250003</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>De Luca</surname><given-names>V.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Ascione</surname><given-names>A.</given-names></name><name><surname>Iannaccone</surname><given-names>T.</given-names></name><name><surname>Chieffi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Autonomic nervous system in the control of energy balance and body weight: personal contributions</article-title>. <source/>Neurol. Res. Int.
<volume>2013</volume>:<fpage>639280</fpage>. <pub-id pub-id-type="doi">10.1155/2013/639280</pub-id><pub-id pub-id-type="pmid">23691314</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Di Bernardo</surname><given-names>G.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>De Luca</surname><given-names>V.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Exercise increases the level of plasma orexin A in humans</article-title>. <source/>J. Basic Clin. Physiol. Pharmacol.
<volume>27</volume>, <fpage>611</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1515/jbcpp-2015-0133</pub-id><pub-id pub-id-type="pmid">27665420</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><name><surname>Moscatelli</surname><given-names>F.</given-names></name><name><surname>Valenzano</surname><given-names>A. A.</given-names></name><name><surname>Monda</surname><given-names>G.</given-names></name><name><surname>Esposito</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Role of Orexin system in obesity</article-title>. <source/>Biol. Med.
<volume>7</volume>:<fpage>248</fpage>
<pub-id pub-id-type="doi">10.4172/0974-8369.1000248</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignot</surname><given-names>E.</given-names></name></person-group> (<year>1998</year>). <article-title>Genetic and familial aspects of narcolepsy</article-title>. <source/>Neurology
<volume>50</volume>, <fpage>S16</fpage>–<lpage>S22</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.50.2_Suppl_1.S16</pub-id><pub-id pub-id-type="pmid">9484418</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monda</surname><given-names>M.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Scognamiglio</surname><given-names>I.</given-names></name><name><surname>Lombardi</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>G. A.</given-names></name><name><surname>Sperlongano</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress</article-title>. <source/>Oxid. Med. Cell. Longev.
<volume>2014</volume>:<fpage>131024</fpage>. <pub-id pub-id-type="doi">10.1155/2014/131024</pub-id><pub-id pub-id-type="pmid">25197428</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monda</surname><given-names>M.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Mondola</surname><given-names>R.</given-names></name><name><surname>Viggiano</surname><given-names>E.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Olanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin A</article-title>. <source/>Peptides
<volume>29</volume>, <fpage>120</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2007.10.016</pub-id><pub-id pub-id-type="pmid">18053616</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Must</surname><given-names>A.</given-names></name><name><surname>Spadano</surname><given-names>J.</given-names></name><name><surname>Coakley</surname><given-names>E. H.</given-names></name><name><surname>Field</surname><given-names>A. E.</given-names></name><name><surname>Colditz</surname><given-names>G.</given-names></name><name><surname>Dietz</surname><given-names>W. H.</given-names></name></person-group> (<year>1999</year>). <article-title>The disease burden associated with overweight and obesity aviva</article-title>. <source/>JAMA
<volume>282</volume>, <fpage>1523</fpage>–<lpage>1529</lpage>. <pub-id pub-id-type="doi">10.1001/jama.282.16.1523</pub-id><pub-id pub-id-type="pmid">10546691</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambu</surname><given-names>T.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Mizukami</surname><given-names>K.</given-names></name><name><surname>Hosoya</surname><given-names>Y.</given-names></name><name><surname>Yanagisawa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>Distribution of orexin neurons in the adult rat brain</article-title>. <source/>Brain Res.
<volume>827</volume>, <fpage>243</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(99)01336-0</pub-id><pub-id pub-id-type="pmid">10320718</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Nagumo</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>S.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Khotib</surname><given-names>J.</given-names></name><name><surname>Miyatake</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>398</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2761-05.2006</pub-id><pub-id pub-id-type="pmid">16407535</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Leighton</surname><given-names>C. E.</given-names></name><name><surname>Boland</surname><given-names>K.</given-names></name><name><surname>Teske</surname><given-names>J. A.</given-names></name><name><surname>Billington</surname><given-names>C.</given-names></name><name><surname>Kotz</surname><given-names>C. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity. <italic>Am. J. Physiol</italic></article-title>. <source/>Endocrinol. Metab.
<volume>303</volume>, <fpage>E865</fpage>–<lpage>E874</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00119.2012</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>C.</given-names></name><name><surname>Faraco</surname><given-names>J.</given-names></name><name><surname>Rogers</surname><given-names>W.</given-names></name><name><surname>Ripley</surname><given-names>B.</given-names></name><name><surname>Overeem</surname><given-names>S.</given-names></name><name><surname>Charnay</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains</article-title>. <source/>Nat. Med.
<volume>6</volume>, <fpage>991</fpage>–<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1038/79690</pub-id><pub-id pub-id-type="pmid">10973318</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>C.</given-names></name><name><surname>Tighe</surname><given-names>D. K.</given-names></name><name><surname>van den Pol</surname><given-names>A. N.</given-names></name><name><surname>de Lecea</surname><given-names>L.</given-names></name><name><surname>Heller</surname><given-names>H. C.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. G.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Neurons containing hypocretin (orexin) project to multiple neuronal systems</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>9996</fpage>–<lpage>10015</lpage>. <pub-id pub-id-type="pmid">9822755</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posar</surname><given-names>A.</given-names></name><name><surname>Pizza</surname><given-names>F.</given-names></name><name><surname>Parmeggiani</surname><given-names>A.</given-names></name><name><surname>Plazzi</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuropsychological findings in childhood narcolepsy</article-title>. <source/>J. Child Neurol.
<volume>29</volume>, <fpage>1370</fpage>–<lpage>1376</lpage>. <pub-id pub-id-type="doi">10.1177/0883073813508315</pub-id><pub-id pub-id-type="pmid">24293310</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainero</surname><given-names>I.</given-names></name><name><surname>De Martino</surname><given-names>P.</given-names></name><name><surname>Pinessi</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Hypocretins and primary headaches: neurobiology and clinical implications</article-title>. <source/>Expert Rev. Neurother.
<volume>8</volume>, <fpage>409</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1586/14737175.8.3.409</pub-id><pub-id pub-id-type="pmid">18345971</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Amemiya</surname><given-names>A.</given-names></name><name><surname>Ishii</surname><given-names>M.</given-names></name><name><surname>Matsuzaki</surname><given-names>I.</given-names></name><name><surname>Chemelli</surname><given-names>R. M.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior</article-title>. <source/>Cell
<volume>92</volume>, <fpage>573</fpage>–<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80949-6</pub-id><pub-id pub-id-type="pmid">9491897</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>C. B.</given-names></name><name><surname>Chou</surname><given-names>T. C.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name></person-group> (<year>2001</year>). <article-title>The sleep switch: hypothalamic control of sleep and wakefulness</article-title>. <source/>Trends Neurosci.
<volume>24</volume>, <fpage>726</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-2236(00)02002-6</pub-id><pub-id pub-id-type="pmid">11718878</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiuchi</surname><given-names>T.</given-names></name><name><surname>Haque</surname><given-names>M. S.</given-names></name><name><surname>Okamoto</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Kageyama</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system</article-title>. <source/>Cell Metab.
<volume>10</volume>, <fpage>466</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2009.09.013</pub-id><pub-id pub-id-type="pmid">19945404</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thannickal</surname><given-names>T. C.</given-names></name><name><surname>Moore</surname><given-names>R. Y.</given-names></name><name><surname>Nienhuis</surname><given-names>R.</given-names></name><name><surname>Ramanathan</surname><given-names>L.</given-names></name><name><surname>Gulyani</surname><given-names>S.</given-names></name><name><surname>Aldrich</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Reduced number of hypocretin neurons in human narcolepsy</article-title>. <source/>Neuron
<volume>27</volume>, <fpage>469</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00058-1</pub-id><pub-id pub-id-type="pmid">11055430</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>MacNeil</surname><given-names>D. J.</given-names></name><name><surname>Van der Ploeg</surname><given-names>L. H.</given-names></name><name><surname>Guan</surname><given-names>X. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Distribution of orexin receptor mRNA in the rat brain</article-title>. <source/>FEBS Lett.
<volume>438</volume>, <fpage>71</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(98)01266-6</pub-id><pub-id pub-id-type="pmid">9821961</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsujino</surname><given-names>N.</given-names></name><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Ichiki</surname><given-names>K.</given-names></name><name><surname>Muraki</surname><given-names>Y.</given-names></name><name><surname>Kilduff</surname><given-names>T. S.</given-names></name><name><surname>Yagami</surname><given-names>K. I.</given-names></name></person-group> (<year>2005</year>). <article-title>Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor</article-title>. <source/>J. Neurosci.<volume>25</volume>, <fpage>7459</fpage>–<lpage>7469</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1193-05.2005</pub-id><pub-id pub-id-type="pmid">16093397</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsunematsu</surname><given-names>T.</given-names></name><name><surname>Fu</surname><given-names>L. Y.</given-names></name><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Ichiki</surname><given-names>K.</given-names></name><name><surname>Tanoue</surname><given-names>A.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Vasopressin increases locomotion through a V1a receptor in orexin/hypocretin neurons: implications for water homeostasis</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>228</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3490-07.2008</pub-id><pub-id pub-id-type="pmid">18171940</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verrotti</surname><given-names>A.</given-names></name><name><surname>Carotenuto</surname><given-names>M.</given-names></name><name><surname>Altieri</surname><given-names>L.</given-names></name><name><surname>Parisi</surname><given-names>P.</given-names></name><name><surname>Tozzi</surname><given-names>E.</given-names></name><name><surname>Belcastro</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Migraine and obesity: metabolic parameters and response to a weight loss programme</article-title>. <source/>Pediatr. Obes.
<volume>10</volume>, <fpage>220</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1111/ijpo.245</pub-id><pub-id pub-id-type="pmid">24990114</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verrotti</surname><given-names>A.</given-names></name><name><surname>Di Fonzo</surname><given-names>A.</given-names></name><name><surname>Agostinelli</surname><given-names>S.</given-names></name><name><surname>Coppola</surname><given-names>G.</given-names></name><name><surname>Margiotta</surname><given-names>M.</given-names></name><name><surname>Parisi</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Obese children suffer more often from migraine</article-title>. <source/>Acta Paediatr. Int. J. Paediatr.
<volume>101</volume>, <fpage>e416</fpage>–<lpage>e421</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2012.02768.x</pub-id><pub-id pub-id-type="pmid">22823862</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Chieffi</surname><given-names>S.</given-names></name><name><surname>Tafuri</surname><given-names>D.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Monda</surname><given-names>M.</given-names></name><name><surname>De Luca</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Laterality of a second player position affects lateral deviation of basketball shooting</article-title>. <source/>J. Sports Sci.
<volume>32</volume>, <fpage>46</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1080/02640414.2013.805236</pub-id><pub-id pub-id-type="pmid">23876006</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Nicodemo</surname><given-names>U.</given-names></name><name><surname>Viggiano</surname><given-names>E.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Monda</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mastication overload causes an increase in O 2 - production into the subnucleus oralis of the spinal trigeminal nucleus</article-title>. <source/>Neuroscience
<volume>166</volume>, <fpage>416</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.12.071</pub-id><pub-id pub-id-type="pmid">20045451</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viggiano</surname><given-names>A.</given-names></name><name><surname>Vicidomini</surname><given-names>C.</given-names></name><name><surname>Monda</surname><given-names>M.</given-names></name><name><surname>Carleo</surname><given-names>D.</given-names></name><name><surname>Carleo</surname><given-names>R.</given-names></name><name><surname>Messina</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Fast and low-cost analysis of heart rate variability reveals vegetative alterations in noncomplicated diabetic patients</article-title>. <source/>J. Diabetes Complicat.
<volume>23</volume>, <fpage>119</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdiacomp.2007.11.009</pub-id><pub-id pub-id-type="pmid">18413209</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villano</surname><given-names>I.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Valenzano</surname><given-names>A.</given-names></name><name><surname>Moscatelli</surname><given-names>F.</given-names></name><name><surname>Esposito</surname><given-names>T.</given-names></name><name><surname>Monda</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Basal forebrain cholinergic system and orexin neurons: effects on attention</article-title>. <source/>Front. Behav. Neurosci.
<volume>11</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2017.00010</pub-id><pub-id pub-id-type="pmid">28197081</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>L. C.</given-names></name><name><surname>Lawrence</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of orexins/hypocretins in alcohol use and abuse</article-title>. <source/>Curr. Top Behav. Neurosci. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1007/7854_2016_55</pub-id><pub-id pub-id-type="pmid">27909991</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wayner</surname><given-names>M. J.</given-names></name><name><surname>Armstrong</surname><given-names>D. L.</given-names></name><name><surname>Phelix</surname><given-names>C. F.</given-names></name><name><surname>Oomura</surname><given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats <italic>in vivo</italic></article-title>. <source/>Peptides
<volume>25</volume>, <fpage>991</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2004.03.018</pub-id><pub-id pub-id-type="pmid">15203246</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>R. H.</given-names></name><name><surname>Jensen</surname><given-names>L. T.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name><name><surname>Fugger</surname><given-names>L.</given-names></name><name><surname>Burdakov</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Control of hypothalamic orexin neurons by acid and CO<sub>2</sub></article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>104</volume>, <fpage>10685</fpage>–<lpage>10690</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0702676104</pub-id><pub-id pub-id-type="pmid">17563364</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Crowder</surname><given-names>T. L.</given-names></name><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Morairty</surname><given-names>S. R.</given-names></name><name><surname>LeWinter</surname><given-names>R. D.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus</article-title>. <source/>J. Physiol.
<volume>574</volume>, <fpage>399</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.108266</pub-id><pub-id pub-id-type="pmid">16627567</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T. R.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Ward</surname><given-names>R.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders</article-title>. <source/>Cell. Signal.
<volume>25</volume>, <fpage>2413</fpage>–<lpage>2423</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2013.07.025</pub-id><pub-id pub-id-type="pmid">23917208</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Beuckmann</surname><given-names>C. T.</given-names></name><name><surname>Willie</surname><given-names>J. T.</given-names></name><name><surname>Hara</surname><given-names>J.</given-names></name><name><surname>Tsujino</surname><given-names>N.</given-names></name><name><surname>Mieda</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2003a</year>). <article-title>Hypothalamic orexin neurons regulate arousal according to energy balance in mice</article-title>. <source/>Neuron
<volume>38</volume>, <fpage>701</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00331-3</pub-id><pub-id pub-id-type="pmid">12797956</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Muraki</surname><given-names>Y.</given-names></name><name><surname>Ichiki</surname><given-names>K.</given-names></name><name><surname>Tsujino</surname><given-names>N.</given-names></name><name><surname>Kilduff</surname><given-names>T. S.</given-names></name><name><surname>Goto</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner</article-title>. <source/>J. Neurophysiol.
<volume>96</volume>, <fpage>284</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01361.2005</pub-id><pub-id pub-id-type="pmid">16611835</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>A.</given-names></name><name><surname>Muraki</surname><given-names>Y.</given-names></name><name><surname>Tsujino</surname><given-names>N.</given-names></name><name><surname>Goto</surname><given-names>K.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name></person-group> (<year>2003b</year>). <article-title>Regulation of orexin neurons by the monoaminergic and cholinergic systems</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>303</volume>, <fpage>120</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(03)00299-7</pub-id><pub-id pub-id-type="pmid">12646175</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Zou</surname><given-names>B.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name><name><surname>Pascual</surname><given-names>C.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Malik</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Hypocretin/orexin neurons contribute to hippocampus-dependent social memory and synaptic plasticity in mice</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>5275</fpage>–<lpage>5284</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3200-12.2013</pub-id><pub-id pub-id-type="pmid">23516292</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokobori</surname><given-names>E.</given-names></name><name><surname>Kojima</surname><given-names>K.</given-names></name><name><surname>Azuma</surname><given-names>M.</given-names></name><name><surname>Kang</surname><given-names>K. S.</given-names></name><name><surname>Maejima</surname><given-names>S.</given-names></name><name><surname>Uchiyama</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Stimulatory effect of intracerebroventricular administration of orexin A on food intake in the zebrafish, <italic>Danio rerio</italic></article-title>. <source/>Peptides
<volume>32</volume>, <fpage>1357</fpage>–<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2011.05.010</pub-id><pub-id pub-id-type="pmid">21616109</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Xue Zhang</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Yan Ren</surname><given-names>Y.</given-names></name><name><surname>Xia Yang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Orexin-A-induced ERK 1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis</article-title>. <source/>Peptides
<volume>54</volume>, <fpage>140</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2013.11.019</pub-id><pub-id pub-id-type="pmid">24321199</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zink</surname><given-names>A. N.</given-names></name><name><surname>Perez-Leighton</surname><given-names>C. E.</given-names></name><name><surname>Kotz</surname><given-names>C. M.</given-names></name></person-group> (<year>2014</year>). <article-title>The orexin neuropeptide system: physical activity and hypothalamic function throughout the aging process</article-title>. <source/>Front. Syst. Neurosci.
<volume>8</volume>:<fpage>211</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2014.00211</pub-id><pub-id pub-id-type="pmid">25408639</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item>
<term>SPA</term>
<def>
<p>spontaneous physical activity</p>
</def>
</def-item>
<def-item>
<term>OX<sub>1</sub>R</term>
<def>
<p>orexin receptor 1</p>
</def>
</def-item>
<def-item>
<term>OX<sub>2</sub>R</term>
<def>
<p>orexin receptor 2</p>
</def>
</def-item>
<def-item>
<term>IL</term>
<def>
<p>infralimbic cortex</p>
</def>
</def-item>
<def-item>
<term>CA2</term>
<def>
<p>hippocampus CA2 area</p>
</def>
</def-item>
<def-item>
<term>BST</term>
<def>
<p>stria terminalis bed nucleus</p>
</def>
</def-item>
<def-item>
<term>PVT</term>
<def>
<p>paraventricular thalamus</p>
</def>
</def-item>
<def-item>
<term>DR</term>
<def>
<p>dorsal raphe</p>
</def>
</def-item>
<def-item>
<term>VTA</term>
<def>
<p>ventral tegmental area</p>
</def>
</def-item>
<def-item>
<term>LC</term>
<def>
<p>locus coeruleus</p>
</def>
</def-item>
<def-item>
<term>LDT</term>
<def>
<p>laterodorsal tegmental nucleus</p>
</def>
</def-item>
<def-item>
<term>PPT</term>
<def>
<p>pedunculopontine nucleus</p>
</def>
</def-item>
<def-item>
<term>TMN</term>
<def>
<p>tuberomammillary nucleus</p>
</def>
</def-item>
<def-item>
<term>Arc</term>
<def>
<p>arcuate nucleus</p>
</def>
</def-item>
<def-item>
<term>DMH</term>
<def>
<p>dorsomedial hypothalamic nucleus</p>
</def>
</def-item>
<def-item>
<term>PVN</term>
<def>
<p>paraventricular nucleus</p>
</def>
</def-item>
<def-item>
<term>LHA</term>
<def>
<p>Lateral hypothalamic area</p>
</def>
</def-item>
<def-item>
<term>BST</term>
<def>
<p>bed nucleus of the stria terminalis</p>
</def>
</def-item>
<def-item>
<term>PVT</term>
<def>
<p>paraventricular nucleus of hypothalamus</p>
</def>
</def-item>
<def-item>
<term>GABA</term>
<def>
<p>gamma-aminobutyric acid</p>
</def>
</def-item>
<def-item>
<term>CO<sub>2</sub></term>
<def>
<p>carbon dioxide</p>
</def>
</def-item>
<def-item>
<term>PSG</term>
<def>
<p>standard polysomnography</p>
</def>
</def-item>
<def-item>
<term>NREM</term>
<def>
<p>Non-Rapid eyes movement</p>
</def>
</def-item>
<def-item>
<term>ICV</term>
<def>
<p>intracerebroventricular</p>
</def>
</def-item>
<def-item>
<term>NEAT</term>
<def>
<p>non-exercise induced thermogenesis</p>
</def>
</def-item>
<def-item>
<term>SPA</term>
<def>
<p>spontaneous physical activity</p>
</def>
</def-item>
<def-item>
<term>LH</term>
<def>
<p>lateral hypothalamus</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>OP</term>
<def>
<p>obesity prone</p>
</def>
</def-item>
<def-item>
<term>OR</term>
<def>
<p>obesity resistant</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson's disease</p>
</def>
</def-item>
<def-item>
<term>VTA</term>
<def>
<p>ventral tegmental area</p>
</def>
</def-item>
<def-item>
<term>LTP</term>
<def>
<p>long-term potentiation</p>
</def>
</def-item>
<def-item>
<term>PTZ</term>
<def>
<p>Pentylenetetrazol</p>
</def>
</def-item>
<def-item>
<term>AT</term>
<def>
<p>orexin/ataxin-3-transgenic</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p>Brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>VEGF</term>
<def>
<p>vascular endothelial growth factor</p>
</def>
</def-item>
<def-item>
<term>IGF-1</term>
<def>
<p>insuline-like growth factor.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>